[1] Wardlaw JM, Smith C, Dichgans M. Mechanisms of sporadic cerebral small vessel disease:insights from neuroimaging[J]. Lancet Neurol, 2013, 12:483-497. [2] Rensma SP, van Sloten TT, Launer LJ, Stehouwer CDA. Cerebral small vessel disease and risk of incident stroke, dementia and depression, and all-cause mortality:a systematic review and meta-analysis[J]. Neurosci Biobehav Rev, 2018, 90:164-173. [3] Nation DA, Wierenga CE, Clark LR, Dev SI, Stricker NH, Jak AJ, Salmon DP, Delano-Wood L, Bangen KJ, Rissman RA, Liu TT, Bondi MW. Cortical and subcortical cerebrovascular resistance index in mild cognitive impairment and Alzheimer's disease[J]. J Alzheimers Dis, 2013, 36:689-698. [4] Bangen KJ, Clark AL, Edmonds EC, Evangelista ND, Werhane ML, Thomas KR, Locano LE, Tran M, Zlatar ZZ, Nation DA, Bondi MW, Delano-Wood L. Cerebral blood flow and amyloid-β interact to affect memory performance in cognitively normal older adults[J]. Front Aging Neurosci, 2017, 9:181. [5] Jann K, Shao X, Ma SJ, Cen SY, D'Orazio L, Barisano G, Yan L, Casey M, Lamas J, Staffaroni AM, Kramer JH, Ringman JM, Wang DJJ. Evaluation of cerebral blood flow measured by 3d pcasl as biomarker of vascular cognitive impairment and dementia (vcid) in a cohort of elderly latinx subjects at risk of small vessel disease[J]. Front Neurosci, 2021, 15:627627. [6] Wang K, Shou Q, MA SJ, Liebeskind D, Qiao XJ, Saver J, Salamon N, Kim H, Yu Y, Xie Y, Zaharchuk G, Scalzo F, Wang DJJ. Deep learning detection of penumbral tissue on arterial spin labeling in stroke[J]. Stroke, 2020, 51:489-497. [7] Dolui S, Li Z, Nasrallah IM, Detre JA, Wolk DA. Arterial spin labeling versus 18F-FDG-PET to identify mild cognitive impairment[J]. Neuroimage Clin, 2020, 25:102146. [8] Nagata K, Yamazaki T, Takano D, Maeda T, Fujimaki Y, Nakase T, Sato Y. Cerebral circulation in aging[J]. Ageing Res Rev, 2016, 30:49-60. [9] Morotti A, Shoamanesh A, Oliveira-Filho J, Schlunk F, Romero JM, Jessel M, Ayres A, Vashkevich A, Schwab K, Cassarly C, Martin RH, Greenberg SM, Qureshi AI, Rosand J, Goldstein JN; Antihypertensive Treatment of Acute Cerebral Hemorrhage 2(ATACH-2) and the Neurological Emergencies Treatment Trials(NETT) Network Investigators. White matter hyperintensities and blood pressure lowering in acute intracerebral hemorrhage:a secondary analysis of the ATACH-2 trial[J]. Neurocrit Care, 2020, 32:180-186. [10] Nasreddine ZS, Phillips NA, Bédirian V, Charbonneau S, Whitehead V, Collin I, Cummings JL, Chertkow H. The Montreal Cognitive Assessment, MoCA:a brief screening tool for mild cognitive impairment[J]. J Am Geriatr Soc, 2005, 53:695-699. [11] Chen X, Li J, Zhang J, He X, Zhu C, Zhang L, Hu X, Wang K. Impairment of the executive attention network in premenopausal women with hormone receptor-positive breast cancer treated with tamoxifen[J]. Psychoneuroendocrinology, 2017, 75:116-123. [12] Dugbartey AT, Townes BD, Mahurin RK. Equivalence of the color trails test and trail making test in nonnative english-speakers[J]. Arch Clin Neuropsychol, 2000, 15:425-431. [13] Cheung RW, Cheung MC, Chan AS. Confrontation naming in Chinese patients with left, right or bilateral brain damage[J]. J Int Neuropsychol Soc, 2004, 10:46-53. [14] Fowler JH, McQueen J, Holland PR, Manso Y, Marangoni M, Scott F, Chisholm E, Scannevin RH, Hardingham GE, Horsburgh K. Dimethyl fumarate improves white matter function following severe hypoperfusion:involvement of microglia/macrophages and inflammatory mediators[J]. J Cereb Blood Flow Metab, 2018, 38:1354-1370. [15] Simon AB, Buxton RB. Understanding the dynamic relationship between cerebral blood flow and the BOLD signal:implications for quantitative functional MRI[J]. Neuroimage, 2015, 116:158-167. [16] Oliveira ÍAF, Guimarães TM, Souza RM, Dos Santos AC, Machado-de-Sousa JP, Hallak JEC, Leoni RF. Brain functional and perfusional alterations in schizophrenia:an arterial spin labeling study[J]. Psychiatry Res Neuroimaging, 2018, 272:71-78. [17] Benedictus MR, Leeuwis AE, Binnewijzend MA, Kuijer JP, Scheltens P, Barkhof F, van der Flier WM, Prins ND. Lower cerebral blood flow is associated with faster cognitive decline in Alzheimer's disease[J]. Eur Radiol, 2017, 27:1169-1175. [18] Shi Y, Thrippleton MJ, Makin SD, Marshall I, Geerlings MI, de Craen AJM, van Buchem MA, Wardlaw JM. Cerebral blood flow in small vessel disease:a systematic review and meta-analysis[J]. J Cereb Blood Flow Metab, 2016, 36:1653-1667. [19] van der Veen PH, Muller M, Vincken KL, Hendrikse J, Mali WP, van der Graaf Y, Geerlings MI; SMART Study Group. Longitudinal relationship between cerebral small-vessel disease and cerebral blood flow:the second manifestations of arterial disease-magnetic resonance study[J]. Stroke, 2015, 46:1233-1238. [20] Jokinen P, Karrasch M, Brück A, Johansson J, Bergman J, Rinne JO. Cognitive slowing in Parkinson's disease is related to frontostriatal dopaminergic dysfunction[J]. J Neurol Sci, 2013, 329:23-28. [21] Starr CJ, Sawaki L, Wittenberg GF, Burdette JH, Oshiro Y, Quevedo AS, McHaffie JG, Coghill RC. The contribution of the putamen to sensory aspects of pain:insights from structural connectivity and brain lesions[J]. Brain, 2011, 134:1987-2004. [22] Mak E, Bergsland N, Dwyer MG, Zivadinov R, Kandiah N. Subcortical atrophy is associated with cognitive impairment in mild Parkinson disease:a combined investigation of volumetric changes, cortical thickness, and vertex-based shape analysis[J]. AJNR Am J Neuroradiol, 2014, 35:2257-2264. [23] Rolls ET. The cingulate cortex and limbic systems for emotion, action, and memory[J]. Brain Struct Funct, 2019, 224:3001-3018. [24] Liston C, Matalon S, Hare TA, Davidson MC, Casey BJ. Anterior cingulate and posterior parietal cortices are sensitive to dissociable forms of conflict in a task-switching paradigm[J]. Neuron, 2006, 50:643-653. [25] Bush G. Cingulate, frontal, and parietal cortical dysfunction in attention-deficit/hyperactivity disorder[J]. Biol Psychiatry, 2011, 69:1160-1167. [26] Hamm AG, Mattfeld AT. Distinct neural circuits underlie prospective and concurrent memory-guided behavior[J]. Cell Rep, 2019, 28:2541-2553. [27] Grueter BE, Schulz UG. Age-related cerebral white matter disease (leukoaraiosis):a review[J]. Postgrad Med J, 2012, 88:79-87. |